Here are Thursday's biggest analyst calls: Nvidia, Amazon, AMD, Cisco, CoreWeave, Sunrun & more

CNBC

13 hours ago

Here are Thursday's biggest calls on Wall Street: Mizuho reiterates Nvidia, Dell and Advanced Micro Devices as outperform The firm raised its price target on several semis companies on Wednesday evening. "Raising Ests/PT for NVDA to $205 (prior $192) AMD to $205 (prior $183) as Hyperscaler capex continues to tick higher, while China adds another tailwind. Raise DELL PT to $160 (prior $150) with strong Tier 2 CSP [cloud service providers] ramps. " Bank of America adds Advanced Micro Devices to the US1 list Bank of America added the stock to its top ideas list. "We are adding Advanced Micro Devices (AMD) to the US 1 List." JPMorgan downgrades Li Auto neutral from overweight JPMorgan downgraded the China EV company on rising competition. "Li Auto (d/g to Neutral): We trim our 2025/26E volume and earnings by ~10-20%, reflecting the fast-changing competitive dynamic facing Li." Read more. Wells Fargo initiates Steel Dynamics as overweight Wells said it likes companies that have exposure to the U.S. "We prefer names with U.S. exposure, as we see steel prices supported by a drop in imports and inventory into year-end that can support mill pricing power. Top picks include STLD and CMC, while we're less confident in imminent relief from excess Chinese supply for more global players TX and MT." UBS initiates SiTime as buy UBS said the semis company has "big AI leverage." "We initiate coverage of SiTime (SITM) with a Buy rating and $260 PT (20% upside)." Citi reiterates CoreWeave as buy Citi said it's sticking with shares of CoreWeave. "The upcoming lock-up may further pressure shares, but we believe buyers will emerge with continuing strong AI demand and a capacity/revenue inflection in Q4/FY26." Rothschild & Co Redburn initiates Regeneron as buy The firm said it's bullish on shares of the biotech company. "For Regeneron , that cycle has been even more extreme: huge sector outperformance since 2012 until a dramatic reversal over the past year. Time for another look at the company? We think so and launch coverage with a Buy recommendation and a $890 price target. Stephens upgrades Asbury Automotive to overweight from equal weight Stephens said in its upgrade of the car detailing company that Asbury is starting to fire on all cylinders. "As part of our work on this note and upgrade, we spoke to numerous auto dealer leaders and operators who know David Hult, worked with him or worked for him. The feedback on CEO Hult is unanimous and consistent. He is a hands-on, attention to details operator." Deutsche Bank reiterates Amazon as buy Deutsche said it's cautiously optimistic on Amazon's grocery strategy. "Early yesterday, Amazon announced what it called "one of the most significant grocery expansions" in the company's history, with free SameDay delivery for US Prime users on perishable orders of $35 or more. While, Amazon's grocery strategy has been a bit of a moving target, and success has been uneven, we do believe that the new product could prove meaningful to Amazon's grocery volume in the medium term." HSBC upgrades dLocal to buy from neutral HSBC upgraded the fintech company following earnings. " dLocal has been exhibiting low earnings volatility and improving disclosures over the past year, and finally this quarter we saw a big EBIT beat (despite some one-off trends) and continued strong volumes." Mizuho upgrades MAA to outperform from neutral Mizuho said the real estate investment trust has an "underleveraged balance sheet." "We upgrade MAA t o Outperform ($150PT), given: accelerating blended rents into 2H25 and accelerating core and FFO/sh growth into 2026e; falling supply across MAA's core markets, suggesting less operating risk and supporting rent improvement; underleveraged balance sheet supporting external growth and further capital deployment." Morgan Stanley reiterates Cisco as overweight Morgan Stanley raised its price target on the stock to $73 per share from $70 following earnings. " Cisco's FQ4 posted upside about in-line with investor expectations, with AI orders accelerating." Cantor Fitzgerald initiates Workday as overweight Cantor said shares of the HR software company has an attractive entry point. "WDAY is a high-quality asset with a strong management team, entrenched competitive position in the enterprise, expanding growth vectors, and latent margin potential. The stock is trading near its all-time low EPS and FCF multiples, which we see as an attractive entry point with a positively skewed risk/reward ratio." Wells Fargo reiterates Sunrun as overweight Wells raised its price target on the stock to $14 per share from $8 and says the solar company remains a top idea. "We're raising our PT to $14/sh, based on a DCF framework: $8/sh of base value and $6/sh of terminal value (2030+). ... We continue to view RUN as a top pick in the residential solar space." Read more. Citi reiterates Microsoft as buy Citi said the tech giant remains a top idea at the firm. " MSFT remains a top pick in software, and we believe this week's announcement is another indication of the company's strong pricing power, which we believed combined with accelerating cloud/AI share gains can drive outsized returns." Barclays initiates Schrodinger as overweight Barclays said shares of the biotech company have plenty more room to run. " Schrödinger (SDGR) has a physics-based drug discovery platform that drives revenues, is used to develop partnered therapeutics programs, and helps fund and internally develop their own early stage pipeline of therapeutics." BTIG upgrades Kratos Defense and Security Solutions to buy from neutral The firm said it sees a slew of positive catalysts ahead for the defense solutions company. "We have consistently called out that the lack of a sizable program of record with steady procurement volumes is something that has kept us from seeing further upside for KTOS shares." Bank of America upgrades Sherwin-Williams to neutral from underperform Bank of America said its "thesis has played out" for Sherwin-Williams . "When we downgraded shares to Underperform, we were concerned about a deceleration in housing markets and sell-side estimates that were overly optimistic. Fundamentally, the thesis has played out, as same-store sales growth has declined to 0.8% and 2Q results and guidance fell short of expectations." Baird upgrades CVS to outperform from neutral Baird said the drug chain retailer is in the midst of a "healthcare benefits turnaround story." "We grow increasingly confident on CVS ' path to unlocking HCB [healthcare benefits] embedded earnings power of ~$5 EPS off 2024."